00069-2522 Elrexfio - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

00069-2522

Brand Name:

Elrexfio

Generic Name:

Elranatamab-bcmm

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Subcutaneous

Substances:

Name: ELRANATAMAB

Strength: 44.0

Unit: mg/1.1mL

Packages:

Code: 00069-2522-02

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-2522-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (0069-2522-01)

Effective Date: Aug. 15, 2023

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

BCMA, CD3

Orphan Drug Designation:

Yes

Status:

In Use